A citation-based method for searching scientific literature

Hanjie Li, Anne M van der Leun, Ido Yofe, Yaniv Lubling, Dikla Gelbard-Solodkin, Alexander C J van Akkooi, Marlous van den Braber, Elisa A Rozeman, John B A G Haanen, Christian U Blank, Hugo M Horlings, Eyal David, Yael Baran, Akhiad Bercovich, Aviezer Lifshitz, Ton N Schumacher, Amos Tanay, Ido Amit. Cell 2019
Times Cited: 274



Se Jin Im, Masao Hashimoto, Michael Y Gerner, Junghwa Lee, Haydn T Kissick, Matheus C Burger, Qiang Shan, J Scott Hale, Judong Lee, Tahseen H Nasti, Arlene H Sharpe, Gordon J Freeman, Ronald N Germain, Helder I Nakaya, Hai-Hui Xue, Rafi Ahmed. Nature 2016
Times Cited: 675




List of shared articles



Times cited

Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity.
Qiang Shan, Sheng'en Hu, Xia Chen, Derek B Danahy, Vladimir P Badovinac, Chongzhi Zang, Hai-Hui Xue. Cell Mol Immunol 2021
16

Organized immune cell interactions within tumors sustain a productive T-cell response.
Maria A Cardenas, Nataliya Prokhnevska, Haydn T Kissick. Int Immunol 2021
2

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.
Faezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin, Hidehiro Yamane, Charles-Antoine Dutertre, Ahad Khalilnezhad, Glennys V Reynoso, Vincent L Coble, Geoffrey M Lynn, Matthew P Mulè,[...]. Nat Immunol 2021
16

MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects.
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, Subhadip Kundu, Zhinuo Jiang, Yiping Fan, Jose Lopez, Rahul Nandre, Peng Zeng, Fatmah Alolaqi,[...]. Nat Immunol 2021
18

CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Moran Yang, Jiaqi Lu, Guodong Zhang, Yiying Wang, Mengdi He, Qing Xu, Congjian Xu, Haiou Liu. J Immunother Cancer 2021
11

Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells.
Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J Chee, Benjamin J Meckiff, Hayley Simon, Emanuela Pelosi, Grégory Seumois, Ferhat Ay, Pandurangan Vijayanand,[...]. Sci Immunol 2021
36

Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer.
Paul Gueguen, Christina Metoikidou, Thomas Dupic, Myriam Lawand, Christel Goudot, Sylvain Baulande, Sonia Lameiras, Olivier Lantz, Nicolas Girard, Agathe Seguin-Givelet,[...]. Sci Immunol 2021
5

Decoding the genetic basis of anti-tumor immunity.
Liangtao Zheng, Zemin Zhang. Immunity 2021
0

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.
Allan Relecom, Maysaloun Merhi, Varghese Inchakalody, Shahab Uddin, Darawan Rinchai, Davide Bedognetti, Said Dermime. J Exp Clin Cancer Res 2021
2

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Weiqin Jiang, Yinjun He, Wenguang He, Guosheng Wu, Xile Zhou, Qinsong Sheng, Weixiang Zhong, Yimin Lu, Yongfeng Ding, Qi Lu,[...]. Front Immunol 2021
7

A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy.
Miguel F Sanmamed, Xinxin Nie, Shruti S Desai, Franz Villaroel-Espindola, Ti Badri, Dejian Zhao, Anthony W Kim, Lan Ji, Tianxiang Zhang, Edward Quinlan,[...]. Cancer Discov 2021
4

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
David A Braun, Kelly Street, Kelly P Burke, David L Cookmeyer, Thomas Denize, Christina B Pedersen, Satyen H Gohil, Nicholas Schindler, Lucas Pomerance, Laure Hirsch,[...]. Cancer Cell 2021
10

Biomechanics of T Cell Dysfunctions in Chronic Diseases.
Sachith D Gunasinghe, Newton G Peres, Jesse Goyette, Katharina Gaus. Front Immunol 2021
2


Memory T-Cell Heterogeneity and Terminology.
Yuki Muroyama, E John Wherry. Cold Spring Harb Perspect Biol 2021
0

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Romain Banchereau, Avantika S Chitre, Alexis Scherl, Thomas D Wu, Namrata S Patil, Patricia de Almeida, Edward E Kadel Iii, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi,[...]. J Immunother Cancer 2021
3

Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer.
Jieti Wang, Ruochen Li, Yifan Cao, Yun Gu, Hanji Fang, Yuchao Fei, Kunpeng Lv, Xudong He, Chao Lin, Hao Liu,[...]. Nat Commun 2021
1

Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.
Jannie Borst, Julia Busselaar, Douwe M T Bosma, Ferry Ossendorp. Eur J Immunol 2021
3

Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.
Jenna L Collier, Sarah A Weiss, Kristen E Pauken, Debattama R Sen, Arlene H Sharpe. Nat Immunol 2021
2


Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.
Simon Eschweiler, James Clarke, Ciro Ramírez-Suástegui, Bharat Panwar, Ariel Madrigal, Serena J Chee, Ioannis Karydis, Edwin Woo, Aiman Alzetani, Somaia Elsheikh,[...]. Nat Immunol 2021
3

PD-1+CXCR5-CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma.
Jiang-Ping Li, Chang-You Wu, Ming-Yuan Chen, Shang-Xin Liu, Shu-Mei Yan, Yin-Feng Kang, Cong Sun, Jennifer R Grandis, Mu-Sheng Zeng, Qian Zhong. J Immunother Cancer 2021
0

CD8+ T cell differentiation and dysfunction in cancer.
Mary Philip, Andrea Schietinger. Nat Rev Immunol 2021
3